Cargando…
The HDAC Inhibitor Phenylbutyrate Reverses Effects of Neonatal Ventral Hippocampal Lesion in Rats
Recent evidence suggests that epigenetic mechanisms play a role in psychiatric diseases. In this study, we considered rats with neonatal ventral hippocampal lesions (NVHL) that are currently used for modeling neurodevelopmental aspects of schizophrenia. Contribution of epigenetic regulation to the e...
Autores principales: | Sandner, Guy, Host, Lionel, Angst, Marie-Josée, Guiberteau, Thierry, Guignard, Blandine, Zwiller, Jean |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059629/ https://www.ncbi.nlm.nih.gov/pubmed/21423460 http://dx.doi.org/10.3389/fpsyt.2010.00153 |
Ejemplares similares
-
Effects of caffeine or RX821002 in rats with a neonatal ventral hippocampal lesion
por: Sandner, Guy, et al.
Publicado: (2014) -
The Inhibition of Histone Deacetylases Reduces the Reinstatement of Cocaine-Seeking Behavior in Rats
por: Romieu, Pascal, et al.
Publicado: (2011) -
4-phenylbutyrate exerts stage-specific effects on cardiac differentiation via HDAC inhibition
por: Li, Yanming, et al.
Publicado: (2021) -
Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line
por: Kusaczuk, Magdalena, et al.
Publicado: (2015) -
Histone Deacetylase Inhibitor Phenylbutyrate Exaggerates Heart Failure in Pressure Overloaded Mice independently of HDAC inhibition
por: Ma, Jing, et al.
Publicado: (2016)